Article Information
History
- March 25, 2022.
Article Versions
- Version 1 (August 5, 2021 - 18:30).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Daman Kaura,*,
- Magda Bucholcb,
- David P. Finnc,
- Stephen Toddd,
- KongFatt Wong-Linb and
- Paula L. McCleana
- aNorthern Ireland Centre for Stratified Medicine, Biomedical Sciences Research Institute, Ulster University, Clinical Translational Research and Innovation Centre (C-TRIC), Altnagelvin Hospital Site, Derry∼Londonderry BT47 6SB, Northern Ireland, UK
- bIntelligent Systems Research Centre, School of Computing, Engineering and Intelligent Systems, Ulster University, Northland Rd, Derry∼Londonderry BT48 7JL, Northern Ireland, UK
- cPharmacology and Therapeutics, School of Medicine, Galway Neuroscience Centre, Human Biology Building, National University of Ireland Galway, University Road, Galway H91 W5P7, Republic of Ireland
- dAltnagelvin Area Hospital, Western Health and Social Care Trust, Derry∼Londonderry BT47 6SB, Northern Ireland, UK
- ↵*Corresponding author: Daman Kaur, kaur-d1{at}ulster.ac.uk, Northern Ireland Centre for Stratified Medicine, Biomedical Sciences Research Institute, Ulster University, C-TRIC, Altnagelvin Hospital Site, Derry∼Londonderry BT47 6SB, Northern Ireland, UK.
Posted March 25, 2022.
Impact of different diagnostic measures on drug class association with dementia progression risk: a longitudinal prospective cohort study
